Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages

참고문헌 (10)

1. Wotherspoon AC, "Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori", Lancet, 342, pp.575~577 (1993)
2. Malfertheiner P, "Management of Helicobacter pylori infection: the Maastricht IV", Florence Consensus Report, 2012, pp.61, 646~664
3. Zucca E, "Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 24(6), pp.vi144~vi148 (2013)
4. Ruskoné-Fourmestraux A, "EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT", Gut, 60, pp.747~758 (2011)
5. Eun Jeong Gong, "Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori -Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma", Gut and Liver, 10(5), pp.706~713 (2016), 거트앤리버 발행위원회
6. Zullo A, "Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review", J Clin Gastroenterol, 47, pp.824~827 (2013)
7. Joo JS, "A thin-layer liquid culture technique for the growth of Helicobacter pylori", Helicobacter, 15, pp.95~302 (2010)
8. Zullo A, "Gastric MALT lymphoma: old and new insights", Ann Gastroenterol, 27, pp.27~33 (2014)
9. Hussell T, "The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori", Lancet, 342, pp.571~574 (1993)
10. Soo-Kyung Park, "Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori", Gut and Liver, 6(2), pp.270~274 (2012), 거트앤리버 발행위원회[DOI]

관련 논문AI추천